v3 Template
P

Pliant Therapeutics Inc.

Biotechnology / Pharmaceuticals SOUTH SAN FRANCISCO, California ~520 employees
Founded
--
Employees (Est.)
~520
26 leaders known
Total Funding
$712.5M
Funding Rounds
3
Last Funding
2023-01-27

About Pliant Therapeutics Inc.

Pliant Therapeutics is dedicated to discovering and developing integrin-based therapies to bring hope to patients. Their mission focuses on understanding the molecular drivers of diseases to create safer and more effective treatments through targeted integrin therapies.

Products & Services

Integrin-Based Therapies:Programs focused on tissue-specific therapies emerging from a proprietary discovery platform.
PLN-101095:A therapy in development for oncology, specifically targeting immune checkpoint inhibitor-refractory advanced solid tumors.

Specialties

Integrin Drug Development Targeted Integrin Therapies Tissue-Specific Therapies Oncology

Funding History

Debug: View Raw Funding Data
# Type Amount Fields Date Fields Investors
1 RT: Public Offering
T: -
FT: Public Offering
A: 287500000
MR: -
FA: approximately $287.5 million
FAN: 287500000
D: 2023-01-27
FD: 2023-01-27
6 investors
2 RT: Public Offering
T: -
FT: Public Offering
A: 250000000
MR: -
FA: 250.0 million
FAN: 250000000
D: 2023-01-24
FD: 2023-01-24
6 investors
3 RT: Public Offering
T: -
FT: Public Offering
A: 175000000
MR: -
FA: $175.0 million
FAN: 175000000
D: 2023-01-23
FD: 2023-01-23
6 investors
Public Offering Latest
2023-01-27
$287.5M
6 investors (Pro only)
Public Offering 2023-01-24
$250.0M
Public Offering 2023-01-23
$175.0M

View 2 more funding rounds with Pro

Unlock Full Funding History

Growth Metrics

+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active

View 3 more growth metrics with Pro

Unlock All Metrics
Mock Up

Team & Leadership

C

Christopher Keenan

Vice President, Investor Relations and Corporate Communications

H

Hal Chapman

Professor, UCSF School of Medicine

R

Rik Derynck

Professor, UCSF Schools of Dentistry and Medicine

D

Dean Sheppard

Professor, UCSF School of Medicine

B

Bill DeGrado

Professor, UCSF School of Pharmacy

B

Bernard Coulie

Director

View 23 more team members with Pro

Unlock Full Team Directory

Recent News

Pliant Therapeutics Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Read more →

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Read more →

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Read more →

View 2 more news articles with Pro

Unlock Full News Feed
Mock Up

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised

Mock Up

Company Details

Industries
Biotechnology / Pharmaceuticals
Company Size
~520 employees (est.)
Locations
SOUTH SAN FRANCISCO, California
South San Francisco, Calif.

Similar Companies

Discover AI-powered company recommendations based on industry, funding, and team profiles.

Upgrade to Pro

Technology Stack

Discover the backend, frontend, and infrastructure technologies powering this company's products.

Upgrade to Pro